Violet Ankunda

Nakiwogo Road
Entebbe, C, Uganda

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Persistent gaps in the prevention of mother-to-child HIV transmission in central Uganda: a case-control study.

Persistent gaps in the prevention of mother-to-child HIV transmission in central Uganda: a case-control study.

Journal: International health
Published: May 17, 2026

Severe Clade I (subclade Ib) mpox in advanced HIV complicated by multidrug-resistant bacterial superinfection and ocular involvement: a case report from Uganda.

Severe Clade I (subclade Ib) mpox in advanced HIV complicated by multidrug-resistant bacterial superinfection and ocular involvement: a case report from Uganda.

Journal: Tropical medicine and health
Published: May 01, 2026

Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreak.

Clinical and microbiological features of critical Clade Ib mpox in adults with HIV during a Ugandan outbreak.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: April 16, 2026

Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.

Knowledge, perceptions, uptake, and determinants of HPV vaccination, and preferred delivery strategies among out-of-school girls in Masaka, Uganda.

Journal: Human vaccines & immunotherapeutics
Published: April 03, 2026

Saliva versus lesion swabs for PCR diagnosis of acute-phase clade Ib mpox in Uganda: a prospective matched hospital cohort study.

Saliva versus lesion swabs for PCR diagnosis of acute-phase clade Ib mpox in Uganda: a prospective matched hospital cohort study.

Journal: The Lancet. Microbe
Published: December 14, 2025

Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in Uganda.

Lesion viral burden, multidrug-resistant superinfection, and HIV-associated haematological vulnerability in hospitalised clade Ib mpox: a prospective cohort study in Uganda.

Journal: EBioMedicine
Published: November 14, 2025

Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.

Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.

Journal: The Lancet. Infectious diseases
Published: July 08, 2025

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.

Neutralization and ADCC reveal divergent spike-subdomain targeting across SARS-CoV-2 vaccine platforms in an African cohort.

Journal: iScience
Published: June 18, 2025

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison.

Journal: Vaccines
Published: January 27, 2025

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.

Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort.

Journal: Vaccines
Published: December 18, 2024

COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda.

COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in Uganda.

Journal: Vaccine
Published: November 22, 2024

Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda.

Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in Uganda.

Journal: Vaccine
Published: November 20, 2024
Showing 1-12 of 23

Last Updated: 09/26/2026